Alpha

Archives
Subscribe
March 10, 2026

Alpha Signal Monitor - Daily Market Briefing | March 10, 2026

Daily Market Research Report

March 10, 2026

Alpha Signal Monitor

Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.

Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts

Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM


This report is generated using advanced AI research capabilities with real-time market data access.


Gold ETFs: Institutional Outlook Snapshot (as of March 10, 2026)

Trading Idea: Buy Rationale (TL;DR): Most tier-1 houses remain constructive on gold into late-2026, citing persistent central-bank buying, renewed private/institutional allocations via ETFs, and an easier Fed/softer USD backdrop; only Citi is notably cautious. Consensus skew and upside targets (GS $5,400; JPM $6,300; BofA $5,000; UBS $4,800 with upside risk) support a Buy stance on broad gold ETFs (GLD, IAU, BAR). (straitstimes.com)

After record gains in 2025, gold continues to be framed by structural reserve diversification and policy/debasement hedging from private investors, while ETF inflows and central-bank purchases remain elevated into 2026; banks generally expect additional Fed easing and a softer USD, though volatility episodes are flagged. (straitstimes.com)

Key Drivers - Sustained central-bank demand (UBS now assumes ~950t in 2026). - Renewed ETF inflows as portfolio hedges; private ‘debasement’ demand persists (GS). - Lower real yields and potential additional Fed cuts supporting non‑yielding assets. - USD softness tailwind to international gold demand. - Ongoing geopolitical/policy uncertainty (trade, fiscal/sanctions) sustaining risk hedging.

Institution Stance Price View Key Evidence Last Update Source
Goldman Sachs Bullish Dec-2026: $5,400/oz (from $4,900) Raised YE‑2026 target; expects private-sector ‘debasement’ hedges to persist, ongoing CB buying (~60 t/month) and sticky ETF holdings; assumes another ~50 bp of Fed easing in 2026. 2026-01-21 https://www.straitstimes.com/business/companies-markets/goldman-says-gold-to-hit-us5400-an-ounce-by-end-2026
Morgan Stanley Positive/Bullish 2026: ~$4,400/oz Research lifted the 2026 forecast to $4,400 (from ~$3,313), citing weaker USD, ETF inflows and CB purchases; warns of demand elasticity at high prices and potential volatility. 2025-10-22 https://www.morganstanley.com/insights/articles/gold-price-forecast-rally-into-2026
JP Morgan Bullish Dec-2026: $6,300/oz; LT raised to $4,500/oz Sees central-bank and investor demand pushing gold to $6,300 by YE‑2026; also raised the long‑term price forecast to $4,500. 2026-02-25 https://www.investing.com/news/commodities-news/jp-morgan-sees-yearend-2026-gold-price-at-6300-per-ounce-4523320
Bank of America Bullish 2026 peak case: $5,000/oz; 2026 avg: ~$4,400/oz Strategists led by Widmer argue another leg higher on investment demand; outline $5,000 peak case with average around $4,400 and scenarios for higher if flows accelerate. 2025-10-13 https://www.investing.com/news/commodities-news/bofa-lifts-gold-target-to-5000oz-sees-silver-staying-in-deficit-4283272
Citigroup Cautious/Bearish Late‑2025/early‑2026: sub‑$3,000/oz; H2‑2026: $2,500–$2,700/oz (base case) Expects investment demand to fade as growth optimism improves; base case sees prices grinding lower into H2‑2026, with downside risks if risk premia abate. 2025-06-17 https://www.investing.com/news/economy-news/citi-sees-gold-below-3000-after-q3-2025-on-weak-demand-growth-optimism-4098601
UBS Positive Dec‑2026: $4,800/oz (central); could reach $5,000 in 1–3Q and as high as $5,400 on upside CIO raises 2026 end‑target to $4,800; projects ~950t CB purchases and ~825t ETF inflows in 2026; flags downside if Fed turns hawkish/ETF outflows resume. 2026-01-30 https://www.ubs.com/global/en/wealthmanagement/insights/chief-investment-office/house-view/daily/2026/latest-30012026/jcr_content/root/contentarea/mainpar/toplevelgrid_copy_co/col_1/textimage_copy_copy.1645661600.file/dGV4dD0vY29udGVudC9kYW0vYXNzZXRzL3dtL2dsb2JhbC9jaW8vaG91c2Utdmlldy9kb2N1bWVudC9jaW8tbW9udGhseS1leHRlbmRlZC1lbi0xNjUzMzU2LnBkZg%3D%3D/cio-monthly-extended-en-1653356.pdf
HSBC Positive with volatility risk 1H‑2026: up to $5,000/oz; 2026 avg trimmed to $4,587/oz; year‑end ~$4,450/oz; range $3,950–$5,050 Sees geopolitical risk and debt supporting H1 strength but warns of potential correction later in 2026 if risks ease or Fed stops cutting. 2026-01-08 https://www.investing.com/news/economy-news/gold-could-hit-5000-an-ounce-in-first-half-of-2026-says-hsbc-4436601
Deutsche Bank Positive 2026 avg: $4,450/oz; range $3,950–$4,950 Lifted 2026 average forecast on stabilizing investor flows and persistent CB demand; notes risks from less Fed easing or slower reserve accumulation. 2025-11-26 https://www.investing.com/news/stock-market-news/deutsche-bank-raises-2026-gold-price-forecast-to-4450oz-4379092

Risk Considerations - Stronger USD and/or higher real yields if the Fed turns more hawkish. - ETF outflows or positioning washouts after crowded longs. - Geopolitical de‑escalation or fiscal consolidation reducing risk premia (HSBC’s caution). - Demand destruction at higher prices (MS notes jewelry softness/price elasticity). - Faster growth/less recession risk reducing allocation to gold (Citi’s base case).

Position portfolios long gold via broad, physically backed ETFs (GLD/IAU/BAR). Use GLD for maximum liquidity and IAU/BAR for fee efficiency; scale in on pullbacks given expected volatility. Maintain risk controls acknowledging Citi’s downside scenario and HSBC’s correction risk; reassess if real yields rise materially or ETF flows reverse. (morganstanley.com)


Stock Ratings — Big 6 U.S. Banks: Target Prices and Ratings (as of March 10, 2026)

Compiled below are the most recent publicly available target prices, ratings, and update dates from six major U.S. institutions (Goldman Sachs, Morgan Stanley, JPMorgan, Bank of America, Citigroup, Wells Fargo) for the requested stocks. Sources are primarily MarketBeat and PriceTargets aggregations, which reflect the latest disclosed figures from each bank’s research notes; many primary research reports are client‑only. Dates are shown in YYYY‑MM‑DD. Consensus values are simple averages of available targets and majority sentiment across the six institutions.

AAPL - Apple Inc.

Across the six banks, Apple screens as a broad Buy/Overweight with recent target lifts following early‑2026 updates; latest JPM and GS actions were in late January 2026.

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Buy $330 2026-01-30 Reiterated/most recent PT seen at $330. https://www.pricetargets.com/NASDAQ/AAPL/
Morgan Stanley Overweight $315 2025-12-05 Raised $305 → $315. https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/
JP Morgan Overweight $325 2026-01-30 Raised $315 → $325. https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/
Bank of America Buy $320 2025-09-17 Raised $270 → $320. https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/
Citigroup Buy $315 2026-01-02 Adjusted $330 → $315. https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/
Wells Fargo Overweight $300 2025-10-31 Raised $290 → $300. https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/

Consensus View - Rating: Buy, Target Price: $317.50 - Average of available PTs across six banks; majority Buy/Overweight.

MSFT - Microsoft Corp.

Consensus skew remains positive despite early‑2026 trims; Goldman most recently set a $600 PT after cutting from $655 on Jan 29, 2026.

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Buy $600 2026-01-29 Cut from $655 → $600; rating maintained. https://www.marketscreener.com/news/latest/GOLDMAN-SACHS-ADJUSTS-PRICE-TARGET-ON-MICROSOFT-TO-600-FROM-655-MAINTAINS-BUY-RATING--45721421/
Morgan Stanley Overweight - 2026-01-29 Reiterated Overweight; latest PT not shown in public listing. https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/
JP Morgan Overweight $550 2026-01-29 Lowered $575 → $550. https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/
Bank of America Buy $520 2026-01-22 Lowered $640 → $520. https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/
Citigroup Buy $635 2026-01-29 Lowered $660 → $635. https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/
Wells Fargo Overweight $615 2026-01-29 Lowered $630 → $615 (also a separate entry showing $600). https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/

Consensus View - Rating: Buy, Target Price: $584.00 - Simple average of available PTs (excluding MS target not publicly shown); majority Buy/Overweight.

GOOGL - Alphabet Inc.

Several banks boosted targets post‑Q4 FY2025 prints; GS to $375 (Buy) in mid‑Jan 2026; Citi at $400 (Outperform).

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Buy $375 2026-01-13 Raised $330 → $375. https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/
Morgan Stanley Overweight $330 2025-10-30 Raised $270 → $330. https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/
JP Morgan Buy - 2026-02-06 Reiterated Buy; latest PT not displayed in public listing. https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/
Bank of America Buy $370 2025-12-02 Raised $335 → $370. https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/
Citigroup Outperform $400 2026-02-06 Reiterated/Set $400. https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/
Wells Fargo Equal Weight $354 2026-02-05 Set $350 → $354. https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/

Consensus View - Rating: Buy, Target Price: $365.80 - Average of available PTs; majority Buy/Overweight with one Hold‑equivalent (Equal Weight).

AMZN - Amazon.com Inc.

Targets were broadly reset lower in early Feb 2026 amid higher AI/data‑center capex guides; MS at $300 (OW), GS at $300 (Buy), WFC at ~$304 (OW).

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Buy $300 2026-01-14 Raised $290 → $300. https://www.pricetargets.com/NASDAQ/AMZN/
Morgan Stanley Overweight $300 2026-02-06 Reiterated; trimmed $315 → $300. https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/
JP Morgan Buy $305 2025-12-02 Most recent public PT shown; JPM reiterated Buy on 2026-02-06 without a PT in public listing. https://www.pricetargets.com/NASDAQ/AMZN/
Bank of America Buy $286 2026-01-26 Lowered $303 → $286. https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/
Citigroup Buy $280 2026-02-10 Lowered $300 → $280 (also saw $320 → $265 on 2026-02-09). https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/
Wells Fargo Overweight $304 2026-02-12 Adjusted $305 → $304. https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/

Consensus View - Rating: Buy, Target Price: $295.83 - Average of the six banks’ latest publicly visible PTs; majority Buy/Overweight.

NVDA - NVIDIA Corp.

Banks remain broadly positive post‑Feb 2026 results, but latest per‑bank PTs from the six requested institutions were not all publicly visible at compile time.

Institution Rating Target Price Last Update Notes Source
Goldman Sachs - - - - https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/
Morgan Stanley - - - - https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/
JP Morgan - - - - https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/
Bank of America - - - - https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/
Citigroup - - - - https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/
Wells Fargo - - - - https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/

Consensus View - Additional bank‑specific PTs needed to compute consensus across the requested institutions.

META - Meta Platforms Inc.

Recent AI/infra investment updates drove target changes across the Street; latest PTs from all six requested institutions not fully available in public listings.

Institution Rating Target Price Last Update Notes Source
Goldman Sachs - - - - https://www.marketbeat.com/stocks/NASDAQ/META/forecast/
Morgan Stanley - - - - https://www.marketbeat.com/stocks/NASDAQ/META/forecast/
JP Morgan - - - - https://www.marketbeat.com/stocks/NASDAQ/META/forecast/
Bank of America - - - - https://www.marketbeat.com/stocks/NASDAQ/META/forecast/
Citigroup - - - - https://www.marketbeat.com/stocks/NASDAQ/META/forecast/
Wells Fargo - - - - https://www.marketbeat.com/stocks/NASDAQ/META/forecast/

Consensus View - Pending additional bank‑specific data.

TSLA - Tesla Inc.

Wells Fargo has recently maintained a bearish stance in public notes; Goldman has been Neutral with periodic PT adjustments; full six‑bank set pending.

Institution Rating Target Price Last Update Notes Source
Goldman Sachs - - - - https://www.pricetargets.com/NASDAQ/TSLA/
Morgan Stanley - - - - https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/
JP Morgan - - - - https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/
Bank of America - - - - https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/
Citigroup - - - - https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/
Wells Fargo - - - - https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/

Consensus View - Pending additional bank‑specific data.

AVGO - AVGO Corp.

Broadcom remains widely owned with strong AI networking optionality; latest six‑bank PTs not all visible publicly at compile time.

Institution Rating Target Price Last Update Notes Source
Goldman Sachs - - - - https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/
Morgan Stanley - - - - https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/
JP Morgan - - - - https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/
Bank of America - - - - https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/
Citigroup - - - - https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/
Wells Fargo - - - - https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/

Consensus View - Pending additional bank‑specific data.

TSM - TSM Corp.

TSMC coverage targets from the six banks were not fully available in public aggregators during this pass.

Institution Rating Target Price Last Update Notes Source
Goldman Sachs - - - - https://www.marketbeat.com/stocks/NYSE/TSM/forecast/
Morgan Stanley - - - - https://www.marketbeat.com/stocks/NYSE/TSM/forecast/
JP Morgan - - - - https://www.marketbeat.com/stocks/NYSE/TSM/forecast/
Bank of America - - - - https://www.marketbeat.com/stocks/NYSE/TSM/forecast/
Citigroup - - - - https://www.marketbeat.com/stocks/NYSE/TSM/forecast/
Wells Fargo - - - - https://www.marketbeat.com/stocks/NYSE/TSM/forecast/

Consensus View - Pending additional bank‑specific data.

Highlights

  • AAPL: Consensus Buy; avg PT ~$317.50 across GS/MS/JPM/BAC/C/WFC (latest updates span 2025‑09‑17 to 2026‑03‑02).
  • MSFT: Consensus Buy; avg PT ~$584.00 (GS $600 on 2026‑01‑29; several banks trimmed late Jan 2026).
  • GOOGL: Consensus Buy; avg PT ~$365.80; GS $375 (2026‑01‑13), Citi $400 (2026‑02‑06), WFC $354 (2026‑02‑05).
  • AMZN: Consensus Buy; avg PT ~$295.83 after early‑Feb 2026 target resets (MS $300, GS $300, WFC ~$304).

Notes: Many sell‑side reports are paywalled; the figures above reflect their latest public footprints via reputable aggregators. I can continue by filling in the remaining five tickers with direct bank‑sourced notes if you can provide client‑access links or specify acceptable secondary sources (e.g., Reuters/Bloomberg summaries).


IPO Calendar

Timeframe: March 10, 2026 to April 10, 2026 (US equity markets)

The coming month’s U.S. new‑listing slate features a mix of: (1) a large cross‑border ADS offering from Japan’s PayPay on Nasdaq, (2) a small‑cap biotech (Salspera) aiming to fund late‑stage oncology programs, and (3) two Nasdaq direct listings (FreeCast and The Metals Royalty Co.) that raise no primary proceeds. This follows the March 6 debut of Medtronic’s diabetes carve‑out MiniMed, suggesting issuance is returning but remains selective and timing‑sensitive amid choppy markets. (renaissancecapital.com)

PayPay Corporation (PAYP)

  • Expected listing date: 2026-03-12 (tentative)
  • Price range: $17.00–$20.00 per ADS
  • Shares offered: 55,000,000 ADS (base offering; ADSs represent PayPay common shares)
  • Exchange: Nasdaq Global Select Market
  • Lead underwriters: Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC
  • Business summary: Japan-based mobile payments and digital finance platform offering QR/barcode payments via the PayPay app, with affiliated banking and securities services; U.S. ADS listing to support growth and platform expansion. (sec.gov)
  • Notes: Company publicly filed an F‑1 on February 12, 2026 and launched its U.S. roadshow on March 2, 2026; Renaissance Capital indicates a ~$1.0B deal and third‑party calendars show an expected March 12, 2026 trade date, but the issuer has not announced a firm pricing or first‑trade date. Final timing, size, and allocations remain subject to market conditions and SEC effectiveness. (sec.gov)
  • Sources: SEC EDGAR — PayPay Corporation F‑1 (CIK 2080845) (filed Feb 12, 2026), PayPay press release — Roadshow launch and Nasdaq GS symbol confirmation (Mar 3, 2026), SoftBank Corp. press release — PayPay F‑1 public filing (Feb 13, 2026), Renaissance Capital — PayPay sets/updates terms and week‑ahead coverage (Mar 2026)

FreeCast, Inc. (CAST)

  • Expected listing date: 2026-03-10 (direct listing)
  • Shares offered: 19,800,000 Class A shares registered for resale (direct listing; no primary capital raised)
  • Exchange: Nasdaq Global Market
  • Lead underwriters: N/A — direct listing (Maxim Group LLC engaged as financial advisor)
  • Business summary: Enterprise streaming technology and media‑infrastructure provider that aggregates and distributes OTT/FAST/AVOD content; pursuing a public direct listing to provide shareholder liquidity without issuing new shares. (nasdaq.com)
  • Notes: S‑1 declared effective February 20, 2026; company initially anticipated a March 3, 2026 listing, later rescheduled to March 10, 2026 on Nasdaq. Direct listings do not set an IPO price, and the issuer receives no offering proceeds. (nasdaq.com)
  • Sources: Nasdaq press release — S‑1 effective and anticipated listing (Feb 20, 2026), Nasdaq press release — Rescheduled Nasdaq direct listing to Mar 10, 2026, SEC EDGAR — FreeCast S‑1/A (registrant CAST), Nasdaq press release — Maxim Group engaged as exclusive financial advisor (Apr 19, 2024)

Salspera, Inc. (TKVA)

  • Expected listing date: Week of 2026-03-23 (pricing/listing TBA)
  • Price range: $14.00–$16.00 per share
  • Shares offered: 5,666,666 primary shares; 850,000 share over‑allotment option (45 days)
  • Exchange: Nasdaq Stock Market (applied)
  • Lead underwriters: Kingswood Capital Partners, LLC (sole bookrunner)
  • Business summary: Clinical‑stage biotech developing ‘live biotherapeutics’ for solid tumors; lead candidate Saltikva (attenuated Salmonella engineered to express IL‑2) targets metastatic pancreatic cancer. IPO proceeds primarily to fund a Phase 3 study, additional Phase 2 programs, and working capital. (sec.gov)
  • Notes: Issuer filed an S‑1 and subsequent free‑writing prospectus indicating expected pricing in the week of March 23, 2026; listing approval on Nasdaq remains pending. Deal terms show a firm‑commitment underwriting with Kingswood as sole bookrunner and a 180‑day lock‑up. Timing may slip depending on market conditions. (sec.gov)
  • Sources: SEC EDGAR — Salspera Issuer Free Writing Prospectus (Mar 3–4, 2026), SEC EDGAR — Salspera preliminary prospectus (S‑1), Renaissance Capital — Salspera sets terms ($85m) and week‑ahead notes

The Metals Royalty Company Inc. (TMCR)

  • Exchange: Nasdaq Stock Market (proposed; direct listing)
  • Lead underwriters: N/A — direct listing (no underwriters)
  • Business summary: Royalty/streaming financing platform focused on critical‑mineral supply chains; anchored by a 2.0% gross overriding royalty on the NORI polymetallic nodule project operated by The Metals Company (Nasdaq: TMC). Direct listing is intended to provide public trading liquidity; the company will not receive proceeds from registered shareholder sales. (nasdaq.com)
  • Notes: Filed a Form F‑1 registration statement on February 27, 2026 for a proposed Nasdaq direct listing; effective date and first trade date remain subject to SEC review and market conditions. Specific registered‑share amounts and reference price have not been disclosed publicly in press materials to date. (nasdaq.com)
  • Sources: Nasdaq press release — TMCR announces public filing for proposed Nasdaq direct listing (Mar 2, 2026), TradingView/Investing.com summaries referencing the F‑1 filing (Feb 27–Mar 2, 2026), Company website — portfolio focus and strategy

Dates, deal sizes, share counts, and underwriter lineups can change quickly until pricing and exchange approval occur; direct listings (e.g., CAST, TMCR) do not have an IPO price and typically involve no primary proceeds to the issuer. Where a date is marked tentative or TBA, it reflects credible calendars/filings but is not issuer‑confirmed. Always consult the latest SEC filings and issuer/exchange announcements before trading. (nasdaq.com)


Sources

  • Stock Ratings: https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/, https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/, https://www.marketbeat.com/stocks/NASDAQ/AVGO/forecast/, https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/, https://www.marketbeat.com/stocks/NASDAQ/META/forecast/, https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/, https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/, https://www.marketbeat.com/stocks/NASDAQ/TSLA/forecast/, https://www.marketbeat.com/stocks/NYSE/TSM/forecast/, https://www.marketscreener.com/news/latest/GOLDMAN-SACHS-ADJUSTS-PRICE-TARGET-ON-MICROSOFT-TO-600-FROM-655-MAINTAINS-BUY-RATING--45721421/, https://www.pricetargets.com/NASDAQ/AAPL/, https://www.pricetargets.com/NASDAQ/AMZN/, https://www.pricetargets.com/NASDAQ/TSLA/
  • IPO Calendar: https://www.nasdaq.com/market-activity/ipos?utm_source=openai, https://www.nasdaq.com/press-release/freecast-engages-maxim-group-as-exclusive-financial-advisor-for-nasdaq-direct-listing?utm_source=openai, https://www.nasdaq.com/press-release/freecast-inc-announces-effectiveness-registration-statement-and-anticipated-listing?utm_source=openai, https://www.nasdaq.com/press-release/metals-royalty-company-inc-announces-public-filing-registration-statement-proposed?utm_source=openai, https://www.renaissancecapital.com/IPO-Center/News/117393/Japanese-fintech-PayPay-sets-terms-for-%241.0-billion-US-IPO?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2080845/000119312526047933/d941409df1.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2084032/000121390026023531/ea0279573-fwp_salspera.htm?utm_source=openai

Disclaimer

This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.

Generated on: 2026-03-10 at 11:23 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.


Powered by Alpha Signal Monitor | Market Intelligence Through AI

Don't miss what's next. Subscribe to Alpha:
Powered by Buttondown, the easiest way to start and grow your newsletter.